Abreviaturas usadas en este Trabajo: IC: intervalo de confianza; RVT: respuesta virológica
temprana; TAAA: terapia antirretroviral altamente activa; IHA: índice histiológico activo; VIH …

Objectives: To assess the clinical-effectiveness and cost-effectiveness of pegylated
interferon-α combined with ribavirin in the treatment of chronic hepatitis C. Data sources …

OBJECTIVES: This study assessed seroprevalence rates of HIV, hepatitis B virus (HBV), and
hepatitis C virus (HCV) among individuals with severe mental illness. METHODS …

Interferon alpha and ribavirin (RBV) combination therapy is associated with decreases in
haemoglobin (Hb) concentrations and anaemia. The aim of this analysis was to better …

OBJECTIVE: The aim of this study was to determine the efficacy of epoetin alfa in alleviating
anemia and minimizing ribavirin (RBV) dose reductions in patients with chronic hepatitis C …

ContextHepatitis C is the leading cause of chronic liver disease in the United States. Several
trials have found that interferon and ribavirin combination therapy is more efficacious than …

OBJECTIVES The efficacy of combination therapy with pegylated interferon (PEG IFN) α plus
ribavirin (RBV) in the retreatment of chronic hepatitis C (CHC) in patients who previously …

Chronic hepatitis C virus infection is common in the United States with an estimated
prevalence of 2.7 million persons. Fortunately, the incidence of new infections has markedly …

Abstract Relatively few patients (≤ 20%) with chronic hepatitis C achieve a sustained
virological response after interferon-α monotherapy. Hence, alternative treatment strategies …

The efficacy of interferon (IFN) combined with ribavirin for the treatment of patients with
hepatitis C who failed to respond to initial IFN therapy is not well established. The primary …